The Implications of the Presence of a Common Non-human Glycan in Recombinant Therapeutic Glycoproteins

Friday, October 12, 2012: 9:15 AM
613 (WSCC)
Darius Ghaderi, PhD , Sialix, Inc., Vista, CA